Veterinary Medicines

BUSCOPAN compositum, soluţie injectabilă

Authorised
  • Metamizole sodium
  • Hyoscine butylbromide
Download as PDF

Product identification

Medicine name:
BUSCOPAN compositum, soluţie injectabilă
Active substance:
  • Metamizole sodium
  • Hyoscine butylbromide
Target species:
  • Dog
  • Cattle
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Intravenous use

Product details

Active substance and strength:
  • Metamizole sodium
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Hyoscine butylbromide
    4.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cattle
      • Meat and offal
        28
        day
  • Intravenous use
    • Dog
    • Cattle
      • Meat and offal
        9
        day
  • Intravenous use
    • Horse
      • Meat and offal
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA03DB04
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • LABIANA LIFE SCIENCES, S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 110170
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 27/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."